IDEAYA director granted 20,000 stock options
IDEAYA Biosciences director Catherine J. Mackey received a stock option grant covering 20,000 shares of Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
IDEAYA Biosciences director Catherine J. Mackey received a stock option grant covering 20,000 shares of Common Stock. The option has an exercise price of $30.57 per share and expires on June 16, 2036. All 20,000 option shares vest on the earlier of the first anniversary of the grant date or immediately before the next Annual Meeting, if she continues serving on the Board.
Insider Trade Summary
Grant/Award: 20,000 shares
Grant/Award
1 txn
Insider
MACKEY CATHERINE J
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 20,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 20,000 contracts (Direct)
Footnotes (1)
- F1. 100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date.
Key Figures
Option grant size: 20,000 shares
Exercise price: $30.57 per share
Expiration date: June 16, 2036
+1 more
4 metrics
Option grant size
20,000 shares
Stock option covering Common Stock
Exercise price
$30.57 per share
Stock option strike price
Expiration date
June 16, 2036
Option term end
Post-transaction derivative holdings
20,000 options
Total stock options held directly after grant
Key Terms
Stock Option (right to buy), exercise price, expiration date, Annual Meeting, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 30.5700"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-16T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Annual Meeting financial
"immediately prior to the Annual Meeting following the date of grant"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
vesting financial
"100% of the shares subject to the option shall vest in full"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did IDEAYA Biosciences (IDYA) report for Catherine J. Mackey?
IDEAYA Biosciences reported that director Catherine J. Mackey received a stock option grant for 20,000 shares of Common Stock at a $30.57 exercise price. This award represents equity-based compensation tied to her continued Board service.
What are the terms of Catherine J. Mackey’s new stock options at IDEAYA Biosciences (IDYA)?
The stock options cover 20,000 underlying shares of Common Stock with a $30.57 exercise price and expire on June 16, 2036. These terms define how long she can exercise the options and at what price.
When do Catherine J. Mackey’s IDEAYA (IDYA) stock options vest?
All 20,000 option shares vest 100% on the earlier of the first anniversary of the June 16, 2036 grant date or immediately before the next Annual Meeting, assuming she continues serving on the Board through the vesting date.
Is Catherine J. Mackey’s IDEAYA (IDYA) option grant a market purchase or compensation award?
The filing classifies the 20,000-share stock option as a grant or award acquisition rather than an open-market purchase. It reflects compensation for Board service, not a discretionary stock purchase in the market.
How many IDEAYA (IDYA) derivative securities does Catherine J. Mackey hold after this grant?
Following this transaction, Catherine J. Mackey holds 20,000 stock options directly according to the filing. These options each relate to one share of IDEAYA Biosciences Common Stock upon exercise at the set $30.57 price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates